Home » Topics » Disease categories and therapies » Infection

Infection
RSS

RSV MAb from MedImmune enters pivotal trials

Dec. 13, 1996

Favorable phase I/II data presented for Xoma's Neuprex as pediatric meningococcemia treatment

Dec. 12, 1996

New antiviral agents from CNRS

Dec. 12, 1996

Milestone reached in Cubist/BMS antiinfective drug collaboration

Dec. 11, 1996

Positive results of fomivirsen in the treatment of CMV retinitis

Dec. 11, 1996

BMS reports results from cefprozil multicenter clinical study in AOM patients

Dec. 10, 1996

U.S. market introduction for novel antifungal formulation

Dec. 10, 1996

Japanese academic researchers isolate new quassinoid compound

Dec. 10, 1996

Pharmacia & Upjohn, McGill University claim antiparasitic MAb

Dec. 9, 1996

Cytovene approved for new indication in U.S.

Dec. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...